# Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCI

> **NCT02792712** · PHASE4 · UNKNOWN · sponsor: **Taipei Veterans General Hospital, Taiwan** · enrollment: 200 (estimated)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Ticagrelor
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT02792712
- **Lead sponsor:** Taipei Veterans General Hospital, Taiwan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2016-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02792712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02792712, "Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCI". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02792712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*